1-6 of 6
Suzanne Kamel-Reid, PhD DABMG, FACMG
Close
Sort by
Journal Articles

Impact of Genomic Alterations on Outcomes in Myelofibrosis Patients Undergoing JAK1/2 Inhibitor Therapy

Jay Spiegel, MD, Caroline Jane McNamara, MBBS, Andrea Arruda, MSc., Tony Panzarella, BSc MSc, James A. Kennedy, MD PhD, Tracy L. Stockley, PhD, Mahadeo Sukhai, BSc, MSc, PhD, Mariam Thomas, PhD, Justyna Bartoszko, MD, Jenny M. Ho, MD, Nancy Siddiq, RN, BScN, Aaron D. Schimmer, MD PhD, Andre C. Schuh, MD FRCPC, Hassan Sibai, MD, Karen W.L. Yee, MD, Jaime O. Claudio, PhD, Rebecca Devlin, PhD, Mark D. Minden, MD PhD, Suzanne Kamel-Reid, PhD DABMG, FACMG, Vikas Gupta, MD FRCP, FRCPath
Journal: Blood
Blood (2016) 128 (22): 4263.
https://doi.org/10.1182/blood.V128.22.4263.4263
Published: 2016
Journal Articles

Utility of Next Generation Sequencing in Prognostication and Therapeutic Decision Making in Cytogenetically Normal AML with DNMT3A Mutations

Arjun Datt Law, MBBS, MDDM, Mahadeo A. Sukhai, BSc, MSc, PhD, Mariam Thomas, PhD, Andrea Arruda, MSc., Narmin Ibrahimova, Steven M. Chan, MD PhD, Vikas Gupta, MD FRCP, FRCPath, Mark D. Minden, MD PhD, Aaron D. Schimmer, MD PhD, Hassan Sibai, MD, Karen W.L. Yee, MD, Dwayne L. Barber, PhD, Tracy L. Stockley, PhD, Suzanne Kamel-Reid, PhD DABMG, FACMG, Andre C. Schuh, MD FRCPC
Journal: Blood
Blood (2016) 128 (22): 2886.
https://doi.org/10.1182/blood.V128.22.2886.2886
Published: 2016
Journal Articles

Treatment-Free Remission Accomplished By Dasatinib (TRAD): Preliminary Results of the Pan-Canadian Tyrosine Kinase Inhibitor Discontinuation Trial

Dennis Dong Hwan Kim, MD PhD, Isabelle Bence-Bruckler, MD FRCPC, Donna L. Forrest, MD, Mary Lynn Savoie, MD, Stephen Couban, MD, Lambert Busque, MD PhD FRCPC, Robert Delage, MD MSc, FRCP, Pierre Laneuville, MD FRCPC, Elena Liew, MD, Anargyros Xenocostas, MD, Kristjan Paulson, MD FRCPC, Suzanne Kamel-Reid, PhD DABMG, FACMG, Jeff H. Lipton, MD PhD, Brian Leber, MD
Journal: Blood
Blood (2016) 128 (22): 1922.
https://doi.org/10.1182/blood.V128.22.1922.1922
Published: 2016
Journal Articles

Prospective Next-Generation Sequencing Molecular Profiling of Myeloid Malignancies: Assessment of Information Benefit and Impact on Patient Care

Suzanne Kamel-Reid, PhD DABMG, FACMG, Mariam Thomas, PhD, Mahadeo A. Sukhai, BSc, MSc, PhD, Dwayne L. Barber, PhD, Swati Garg, PhD, Maksym Misyura, PhD, Roozbeh Dolatshahi, Djamel Harbi, Tong Zhang, Anna Porwit, MDPhD, Jan M.A. Delabie, MD PhD, Narmin Ibrahimova, Mohamed Shanavas, MD FRACP, FRCPA, Karen W.L. Yee, MD, Trevor J. Pugh, PhD, Philippe Bedard, MD, Aaron D. Schimmer, MD PhD, Tracy L. Stockley, PhD, Vikas Gupta, MD FRCP, FRCPath, Mark D. Minden, MD PhD, Andre C Schuh, MD FRCPC
Journal: Blood
Blood (2015) 126 (23): 3848.
https://doi.org/10.1182/blood.V126.23.3848.3848
Published: 2015
Journal Articles

Predictive Value of Molecular Remissions Post Consolidation Chemotherapy in Patients with Core Binding Factor (CBF) Acute Myeloid Leukemias – a Single Centre Analysis

Uday Deotare, MD DM, Marwan Shaheen, MD, Joseph M. Brandwein, MD FRCPC, Bethany Gill, BSc, MMath, Suzanne Kamel-Reid, PhD DABMG, FACMG, Karen W.L. Yee, MDFRCPC, Anna Rydlewski, MD, Andrzej Lutynski, MD, Amr Rostom, MDCFPC, Aaron D Schimmer, MDPhD, Mark D. Minden, MD PhD, Vikas Gupta, MD FRCP, FRCPath, Matthew D. Seftel, MRCP, FRCPC, MPH, Naheed Alam, MBBS,MD, Andre C Schuh, MD FRCPC
Journal: Blood
Blood (2014) 124 (21): 3693.
https://doi.org/10.1182/blood.V124.21.3693.3693
Published: 2014
Journal Articles

Mixed Fields on RHD Typing As an Indicator of Malignancy-Associated Loss of Heterozygosity on Chromosome 1p in Myeloid Neoplasm

Signy Chow, MD FRCPC, Jacob M Pendergrast, MD FRCPC, Gorka Ochoa-Garay, Vikas Gupta, MD FRCP, FRCPath, Muhammad Ejaz Munir, MBBS, FRCS, Cuihong Wei, PhD FCCMG, Kenneth J Craddock, MD FRCPC, Suzanne Kamel-Reid, PhD DABMG, FACMG, Christine Cserti-Gazdewich, MD FRCPC
Journal: Blood
Blood (2014) 124 (21): 5105.
https://doi.org/10.1182/blood.V124.21.5105.5105
Published: 2014